Bimedoc
- Company typePrivate
- Founded2018
- HeadquartersLyon, France
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Bimedoc firmographics
Firmographics- Name
- Bimedoc
- Legal name
- Bimedoc
- Website
- https://bimedoc.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Bimedoc industry classification
Industry- Product category
- Pharmaceutical Care Software
- NAICS
- Ambulatory Health Care Services (621), Offices of Physicians (6211)
- SIC
- Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)
- akta.pro primary industry
- Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)
- akta.pro secondary industries
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Medication Adherence, Reminders & Patient Support (HLACAKAF)
Keywords
Where Bimedoc is headquartered
LocationHeadquarters
- HQ city
- Lyon
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Bimedoc business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- Pharmacy Software Subscription (Officine): Monthly SaaS subscription for community pharmacies. Tiered model with a free Discovery tier (messaging only) and a Premium paid tier (60€ HT/month) including full pharmaceutical analysis, patient records, medication reviews, consultations, screenings, appointments, and SMS reminders. Additional SMS packs at 40€ HT per 500 SMS.
- Healthcare Establishment Software (Etablissement de santé): Annual subscription model for hospitals and health facilities with three tiers: Découverte (0€/month), Conciliation médicamenteuse, and Chimiothérapie orale. Pricing is quote-based, targeting enterprise healthcare institutions requiring medication reconciliation and oncology patient follow-up.
- CPTS/MSP Platform Subscription: Annual subscription forCPTS (Communautés Professionnelles Territoriales de Santé) and MSP (Maisons de Santé Pluriprofessionnelles), priced by size tier (300-460€/month) including protocol management, secure messaging, and administrator training. Additional local protocol creation at 500€ HT per protocol.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free messaging-only tier for community pharmacies |
| Subscription | Monthly | Full pharmaceutical care platform for community pharmacies at 60€ HT/month |
| Freemium | Annual | Free discovery tier for healthcare establishments |
| Subscription | Annual | Medication reconciliation tier for hospitals |
| Subscription | Annual | Oral chemotherapy patient follow-up tier for hospitals |
| Subscription | Annual | Tier 1 CPTS (smallest size) |
| Subscription | Annual | Tier 2 CPTS |
| Subscription | Annual | Tier 3 CPTS |
| Subscription | Annual | Tier 4 CPTS (largest size) |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
Bimedoc product offering
Product offeringCore offering
Bimedoc is a cloud-based SaaS pharmaceutical care platform that enables community pharmacies, hospitals/health establishments, and CPTS/MSP coordinated care structures in France to digitize and streamline pharmaceutical care activities. The platform combines a Class I certified medical device for pharmaceutical analysis (Bimedoc Expert), AI-assisted prescription transcription (Bimedoc Reco), secure inter-professional messaging (Bimedoc Team), and AI-assisted dispensing control into an integrated solution that bridges the city-hospital gap. Customers subscribe to access modules for medication reviews, medication reconciliation, pharmaceutical consultations (anticoagulants, oral chemotherapy, pregnant women), screenings (angina, cystitis, COVID/flu), vaccination management, cooperation protocol management, and appointment scheduling.
Product overview
Bimedoc is a modular SaaS pharmaceutical care platform serving three customer segments — community pharmacies (pharmacie d'officine), health establishments (établissements de santé, hospitals and CLCCs), and coordinated care structures (CPTS/MSP) — with a suite of interconnected modules. The core platform is powered by Bimedoc Expert (a Class I medical device AI assistant for pharmaceutical analysis), Bimedoc Team (secure instant messaging), and Bimedoc Reco (intelligent prescription transcription). Add-on modules cover: medication reconciliation (Conciliation médicamenteuse), Shared Medication Reviews (Bilan partagé de médication), Health Prevention Assessments (Bilan de prévention santé), pharmaceutical consultations (anticoagulants, oral chemotherapy, pregnant women, antalgic, smoking cessation), screening (angine, cystite, COVID/flu), assisted dispensing control, patient eligibility detection (Bimedoc Detect), appointment scheduling, and cooperation protocol management for CPTS. The platform integrates with pharmacy management systems (LGO), national health databases (SIDEP), secure messaging networks (MsSanté, Apicrypt), and partner platforms (Medeo teleconsultation, PHARMONY, MesVaccins.net).
Differentiator
Problem solved
Functional benefit
Brands
- Bimedoc Expert: Pharmaceutical analysis assistant module - a Class I medical device providing medication database, drug interaction detection, inappropriate medication detection, and anticholinergic load calculation.
- Bimedoc Detect
- Bimedoc Team
- Bimedoc Reco
Products and services
- Bimedoc Pharmacie d'Officine Dedicated module for French community pharmacies covering compensated pharmaceutical activities: Shared Medication Reviews (Bilan Partagé de Médication), Health Prevention Assessments, pharmaceutical consultations (anticoagulants, oral chemotherapy, pregnant women), screening tests (angina, cystitis, COVID-19/flu), vaccination management, prescription transcription, dispensing control, appointment scheduling, and patient reminders.
- Bimedoc Établissement de Santé Dedicated module for hospitals and health establishments covering medication reconciliation (conciliation médicamenteuse), pharmaceutical decision support, oral chemotherapy patient follow-up, and city-hospital communication to ensure continuity of care at all transition points in the patient journey.
- Bimedoc Solution CPTS / MSP Digital solution for Communautés Professionnelles Territoriales de Santé (CPTS) and Maisons de Santé Pluriprofessionnelles (MSP) to create, conduct, and track national and local cooperation protocols, coordinate care across professions, manage ACI reporting to ARS, and use integrated secure messaging for multidisciplinary collaboration.
- Bimedoc Expert
Quantifiable outcome
- Reduced antigen test time from 15 minutes to 5 minutes per patient
- +2 more outcomes
Companies that use Bimedoc
Customer profileNamed customers17 records
Segments3 records
Ideal customer profiles3 records
Bimedoc technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration9 records
AI capability11 records
Feature7 records
Bimedoc partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core.
- SYADEM (MesVaccins.net)coreStrategic partnership announced March 5, 2026 integrating SYADEM's MentorPro® vaccination decision support system (SADV) directly into the Bimedoc platform. Pharmacists in both community pharmacies and hospitals will be able to perform personalized vaccination diagnostic assessments based on patient vaccination history, identify missing vaccinations, and integrate vaccination coverage into coordinated pharmaceutical care. A second phase will trigger automatic vaccination audits upon Carte Vitale insertion.
- AtyoscoreAWS-specialized cloud infrastructure partner engaged from December 2024 to April 2026 to audit and implement 29 infrastructure recommendations covering security (data encryption, MFA, WAF, private networks), high availability (multi-AZ deployment, automatic failover, daily backups), governance (IaC, monitoring dashboards, CI/CD pipelines), and cost optimization. All 29 recommendations were implemented.
- URPS Pharmaciens Hauts-de-FrancecoreCollaboration with URPS Pharmaciens Hauts-de-France during Mois Sans Tabac (No Tobacco Month), November 2023. Bimedoc provides the digital platform for smoking cessation support via pharmacists over a 4-month program with 6 consultations per patient, generating 100€ remuneration per patient for pharmacists. HDF Addictions and ARS Hauts-de-France are also partners.
- URPS Pharmaciens Hauts-de-FrancecoreCollaboration with URPS Pharmaciens Hauts-de-France, announced October 23, 2023, with support from ARS Hauts-de-France. Bimedoc provides the digital platform for an osteoporosis screening experiment targeting women over 45 in pharmacies across Oise, Somme, and Pas-de-Calais departments, until December 2023. The 20-minute consultation is valued at 30€ and includes risk evaluation, nutritional analysis, and prevention education.
- Giphar GroupcorePartnership with Giphar, a major French pharmacy group, announced June 7, 2023. The collaboration aims to offer Bimedoc's pharmaceutical care software solutions to Giphar's network of pharmacies, strengthening the digital transformation of pharmacy services across the group.
- PULSALYScoreDeep Tech partnership with PULSALYS, the Deep Tech incubator and accelerator for Lyon and Saint Etienne, renewed May 22, 2023. Bimedoc is integrating two predictive algorithms from DDI-Predictor (developed by Prof. Michel Tod's team at the LBBE laboratory, Université Claude Bernard Lyon 1) into its clinical decision support system: (1) drug dosage adjustment based on renal function, and (2) prediction of adverse drug events. The collaboration leverages research from CNRS, Hospices Civils de Lyon, Inria, and Université Jean Monnet.
- OMéDIT / ARS NormandiecoreOMéDIT (Observatoire des Médicaments, Dispositifs médicaux et Innovations Thérapeutiques) and ARS Normandie selected Bimedoc for the Optimedoc program, a medication optimization initiative for elderly patients in Normandy. Bimedoc deployed medication reconciliation across 17 health establishments in Normandy as part of this Article 51 program, with approximately 200 community pharmacists and 40 general practitioners participating.
- Centre Becquerel (Onco'Link)coreBimedoc participates in the Onco'Link Article 51 care pathway for patients under oral chemotherapy, involving Centre Becquerel and other cancer centers. The platform facilitates communication between hospital pharmacists and community pharmacists, manages patient follow-up, and integrates with billing systems for the care pathway.
- CHU de Lille, CHU d'Amiens, Université de Lille, URPS Pharmaciens HdFcoreBimedoc developed a collaborative personalized pharmaceutical care plan (PPP) tool for the IATROPREV Article 51 experiment in Hauts-de-France, led by CHU de Lille and CHU d'Amiens with partners including Université de Lille, URPS Pharmaciens Hauts-de-France, liberal physicians, ARS Hauts-de-France, and GIP Santé Numérique Hauts-de-France. The platform enables asynchronous multi-professional collaboration via RCP (plenary meetings) for elderly patients over 75.
Scale indicators9 records
Recent moves15 records
Expansion highlights6 records
Bimedoc competitors and assessment
Company assessmentBroad incumbents
- Doctolib: Doctolib is France's dominant healthcare booking, telehealth, and practice management platform with tens of millions of patients. While Bimedoc is pharmacy-focused and Doctolib is physician-focused, they overlap in secure messaging, appointment scheduling, and care pathway coordination — areas where Doctolib's massive consumer reach could be leveraged to enter pharmacy workflows.
- Cegedim (Maiia / CLM / RM Ingénierie): Cegedim is a major French healthcare software incumbent offering physician practice management, electronic health records, secure messaging, and Maiia (formerly Docavenue) teleconsultation/coordination tools. Its broad portfolio overlaps with Bimedoc in CPTS coordination, secure health messaging, and pharmacy-facing workflows, but serves a much wider healthcare ecosystem.
Direct peers
- LGPI (Cegedim): LGPI is a leading French LGO vendor serving a large share of French community pharmacies, owned by Cegedim. LGPI's position at the counter-level pharmacy workflow makes it directly comparable to where Bimedoc's AI-assisted dispensing control and Detect eligibility modules operate.
- Medeo: Medeo is a French teleconsultation platform interoperable with Bimedoc for medication reviews. While Medeo focuses on physician teleconsultation and Bimedoc on pharmaceutical care, the two platforms target overlapping professional user bases (pharmacists, physicians) for coordinated medication management workflows.
- WinPharma: WinPharma is one of France's largest LGO vendors serving thousands of community pharmacies. As a core pharmacy counter software provider, WinPharma is structurally comparable to Bimedoc at the dispensing workflow layer, and represents both a competitor and a potential integration channel for Bimedoc's dispensing control and decision support modules.
- Vidal Group: Vidal is the leading independent drug database and clinical decision support provider in France, widely used by physicians, pharmacists, and hospitals. Bimedoc Expert integrates and competes with Vidal-style drug reference data for pharmaceutical analysis, drug interaction detection, and clinical decision support workflows within community pharmacies and hospitals.
- Pharmony: Pharmony is a French LGO (Logiciel de Gestion Officine) vendor with integrated dispensing control and patient eligibility detection at the pharmacy counter. Bimedoc has a commercial and technical partnership with Pharmony, but the two also overlap in delivering dispensing safety and eligibility functionality to community pharmacies.
- Alliadis: Alliadis is a major French LGO (pharmacy management software) provider used by thousands of community pharmacies. As a competing LGO and potential integration partner, Alliadis is comparable to Bimedoc at the pharmacy counter, where integrated dispensing control and eligibility detection are key differentiators.
- Apicrypt: Apicrypt is one of France's leading secure health messaging networks for healthcare professionals, deeply integrated by Bimedoc Team. Bimedoc Team and Apicrypt compete and interoperate in secure messaging for city-hospital communication, with Apicrypt providing the established network that Bimedoc Team connects into.
- SYADEM (MesVaccins.net): SYADEM operates MesVaccins.net and the MentorPro vaccination decision support system (SADV), recently announced as a strategic partner to integrate into Bimedoc. SYADEM competes with Bimedoc in clinical decision support for vaccination and patient eligibility detection in pharmacies and hospitals, while now also partnering on integration.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Bimedoc social profiles
Digital presenceBimedoc compliance and trust
Trust signalCompliance2 records
Bimedoc financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bimedoc leadership team
Management profileNumber of profiles
Profiles4 records
Bimedoc funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bimedoc M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bimedoc
What does Bimedoc do?
Bimedoc is a cloud-based SaaS pharmaceutical care platform that enables community pharmacies, hospitals/health establishments, and CPTS/MSP coordinated care structures in France to digitize and streamline pharmaceutical care activities. The platform combines a Class I certified medical device for pharmaceutical analysis (Bimedoc Expert), AI-assisted prescription transcription (Bimedoc Reco), secure inter-professional messaging (Bimedoc Team), and AI-assisted dispensing control into an integrated solution that bridges the city-hospital gap. Customers subscribe to access modules for medication reviews, medication reconciliation, pharmaceutical consultations (anticoagulants, oral chemotherapy, pregnant women), screenings (angina, cystitis, COVID/flu), vaccination management, cooperation protocol management, and appointment scheduling.
Is Bimedoc a public or private company?
Bimedoc is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bimedoc founded?
Bimedoc was founded in 2018. It employs 11 to 50 people.
Where is Bimedoc based?
Bimedoc is headquartered in Lyon, France, in the Europe region.
How does Bimedoc make money?
Three revenue lines are on record. Pharmacy Software Subscription (Officine) is the primary driver. The others are healthcare Establishment Software (Etablissement de santé) and CPTS/MSP Platform Subscription.
Who are Bimedoc's main competitors?
Broad incumbents on record are Doctolib and Cegedim (Maiia / CLM / RM Ingénierie). Direct peers are LGPI (Cegedim), Medeo, WinPharma, Vidal Group, Pharmony, Alliadis, Apicrypt and SYADEM (MesVaccins.net).
Does Bimedoc have an API?
No public API is recorded for Bimedoc.
What industry is Bimedoc in?
Bimedoc's product category is Pharmaceutical Care Software. Its primary akta.pro industry code is HLACAKAH, Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools, with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 621 and its SIC code is 8090.